Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 4/2015

01-08-2015 | Short Research Report

Evaluation of parenteral nutrition use in patients undergoing major upper gastro-intestinal surgery

Authors: Barbara Deleenheer, Peter Declercq, Hans Van Veer, Philippe Nafteux, Isabel Spriet

Published in: International Journal of Clinical Pharmacy | Issue 4/2015

Login to get access

Abstract

Background After major upper gastro-intestinal surgery, enteral feeding is often hampered. There is still no consensus on which route of nutrition is preferable in patients undergoing this type of surgery. Current ESPEN guidelines recommend parenteral nutrition in undernourished patients, if caloric requirements cannot be met orally/enterally within 7 days and enteral nutrition is contraindicated. Objective The current practice of systematic parenteral nutrition at the thoracic surgery ward of the University Hospitals Leuven was evaluated based on the ESPEN guidelines. Method This prospective observational study included patients undergoing upper gastro-intestinal surgery and receiving postoperative parenteral nutrition. Parenteral nutrition use was considered appropriate when patients were undernourished and unable to obtain adequate caloric requirements by oral or enteral feeding within 7 days. Results Twenty-five out of 35 patients were nutritionally at risk. In 9 of 25 patients, the indication for parenteral nutrition was considered justified. As the intestinal tract below the anastomosis site remains accessible in the total studied population, enteral nutrition might be an option. Unfortunately, an appropriate jejunostomy tube was not available at our institution. Conclusion In accordance to the ESPEN guidelines, enteral nutrition can replace parenteral nutrition in most thoracic surgery patients, but only if an appropriate enteral access is available.
Literature
1.
go back to reference Alivizatos V, Gavala V, Alexopoulos P, Apostolopoulos A, Bajrucevic S. Feeding tube-related complications and problems in patients receiving long-term home enteral nutrition. Indian J Palliat Care. 2012;18(1):31–3.PubMedCentralPubMedCrossRef Alivizatos V, Gavala V, Alexopoulos P, Apostolopoulos A, Bajrucevic S. Feeding tube-related complications and problems in patients receiving long-term home enteral nutrition. Indian J Palliat Care. 2012;18(1):31–3.PubMedCentralPubMedCrossRef
2.
go back to reference Tapia J, Murguia R, Garcia G, de los Monterols PE, Oñate E. Jejunostomy: techniques, indications, and complications. World J Surg. 1999;23(6):596–602.PubMedCrossRef Tapia J, Murguia R, Garcia G, de los Monterols PE, Oñate E. Jejunostomy: techniques, indications, and complications. World J Surg. 1999;23(6):596–602.PubMedCrossRef
3.
go back to reference Seike J, Tangoku A, Yuasa Y, Okitsu H, Kawakami Y, Sumitomo M. The effect of nutritional support on the immune function in the acute postoperative period after oesophageal cancer surgery: total parenteral nutrition versus enteral nutrition. J Med Invest. 2011;58(1–2):75–80.PubMedCrossRef Seike J, Tangoku A, Yuasa Y, Okitsu H, Kawakami Y, Sumitomo M. The effect of nutritional support on the immune function in the acute postoperative period after oesophageal cancer surgery: total parenteral nutrition versus enteral nutrition. J Med Invest. 2011;58(1–2):75–80.PubMedCrossRef
4.
go back to reference Xiao-Bo Y, Qiang L, Xiong Q, Zheng R, Jian Z, Jian-Hua Z, et al. Efficacy of early postoperative enteral nutrition in supporting patients after esophagectomy. Minerva Chir. 2014;69(1):37–46.PubMed Xiao-Bo Y, Qiang L, Xiong Q, Zheng R, Jian Z, Jian-Hua Z, et al. Efficacy of early postoperative enteral nutrition in supporting patients after esophagectomy. Minerva Chir. 2014;69(1):37–46.PubMed
5.
go back to reference Fujita T, Daiko H, Nishimura M. Early enteral nutrition reduces the rate of life-threatening complications after thoracic oesophagectomy in patients with oesophageal cancer. Eur Surg Res. 2012;48(2):79–84.PubMedCrossRef Fujita T, Daiko H, Nishimura M. Early enteral nutrition reduces the rate of life-threatening complications after thoracic oesophagectomy in patients with oesophageal cancer. Eur Surg Res. 2012;48(2):79–84.PubMedCrossRef
6.
go back to reference Braga M, Ljungqvist O, Soeters P, Fearon K, Weimann A, Bozzetti F. ESPEN guidelines on parenteral nutrition: surgery. Clin Nutr. 2009;28(4):378–86.PubMedCrossRef Braga M, Ljungqvist O, Soeters P, Fearon K, Weimann A, Bozzetti F. ESPEN guidelines on parenteral nutrition: surgery. Clin Nutr. 2009;28(4):378–86.PubMedCrossRef
7.
go back to reference Kondrup J, Rasmussen HH, Hamberg O, Stanga Z, Ad hoc Espen Working Group 1. Nutritional risk screening (NRS-2002): a new method based on an analysis of controlled clinical trials. Clin Nutr. 2003;22(3):321–36.PubMedCrossRef Kondrup J, Rasmussen HH, Hamberg O, Stanga Z, Ad hoc Espen Working Group 1. Nutritional risk screening (NRS-2002): a new method based on an analysis of controlled clinical trials. Clin Nutr. 2003;22(3):321–36.PubMedCrossRef
8.
go back to reference Weimann A, Braga M, Harsanyi L, Laviano A, Ljungqvist O, Soeters P. ESPEN guidelines on enteral nutrition: surgery including organ transplantation. Clin Nutr. 2006;25(2):224–44.PubMedCrossRef Weimann A, Braga M, Harsanyi L, Laviano A, Ljungqvist O, Soeters P. ESPEN guidelines on enteral nutrition: surgery including organ transplantation. Clin Nutr. 2006;25(2):224–44.PubMedCrossRef
Metadata
Title
Evaluation of parenteral nutrition use in patients undergoing major upper gastro-intestinal surgery
Authors
Barbara Deleenheer
Peter Declercq
Hans Van Veer
Philippe Nafteux
Isabel Spriet
Publication date
01-08-2015
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 4/2015
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-015-0099-y

Other articles of this Issue 4/2015

International Journal of Clinical Pharmacy 4/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine